Skip to main content

Table 5 Changes in the severity of CTS in the two groups after treatment

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Group Condition Normal
N(%)
Mild
N(%)
Moderate
N(%)
Control Before 0(0%) 15 (75%) 5 (25%)
After 0(0%) 16 (80%) 14 (20%)
Treat Before 0(0%) 12 (57%) 9(43%)
After 3(14%) 10(48%) 8 (38%)